TLJ-26417-70175
4 vaccinations
8 coded responses
35 check-ins
8 free-text entries
3 call cases
- Sex
- —
- Age at first dose
- 46-50
- ZIP prefix
- 751 / TX
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Registered in v-safe
-
2021-02-05
Dose 1 — Pfizer-BioNTech
- 2021-02-05
-
2021-02-06
Survey response — days 1–6 daily, dose 1MedDRA: Emotional disorder — Feeling: Fair · Site: PainFree text: EmotionalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-02-26
-
2021-03-05
Dose 2 — Pfizer-BioNTech
- 2021-03-05
- 2021-03-06
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-08
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Poor · Joint pains, Fatigue or tiredness · Be unable to workFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Chills, Headache, Joint pains, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: A few swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-12
- 2021-03-19
- 2021-03-26
-
2021-04-02
Survey response — day 28, dose 2MedDRA: Pain, Paranasal sinus discomfort — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sinus pressure and painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-16
-
2021-06-04
Survey response — 3 months, dose 2MedDRA: Nausea, Vomiting — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Nausea and vomiting for a few hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-03
-
2021-11-04
Dose 3 — Moderna
-
2022-03-05
Survey response — 12 months, dose 2MedDRA: COVID-19, Pneumonia, Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: COVID 19 positive and secondary lung and sinus infectionsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-08
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-07-18
Dose 4 — Pfizer-BioNTech
- 2022-07-22
- 2022-07-25
- 2022-08-01
- 2022-08-08
- 2022-08-15
- 2022-08-22
-
2022-08-29
Survey response — day 42, dose 4MedDRA: Office visit, Vitreous floaters — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Sudden, large floater appeared in my right eye; was evaluated for a retina tear and no tear was found · Healthcare visit (other): OphthalmologistMedDRA releases: 2024-11 · check-in free text available
-
2022-08-29
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-08-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-17
Survey response — 3 months, dose 4MedDRA: Brain fog, Dyspnoea, Fatigue, Headache, Post-acute COVID-19 syndrome, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Extreme fatigue, shortness of breath, brain fog, headaches I have been diagnosed with long-COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-18
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | |
| 2 | 2021-03-05 | Pfizer-BioNTech | |
| 3 | 2021-11-04 | Moderna | No |
| 4 | 2022-07-18 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Emotional
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): A few swollen lymph nodes
Release 6 — day 28, dose 2
Symptoms: Sinus pressure and pain
Release 8 — 3 months, dose 2
Symptoms: Nausea and vomiting for a few hours
Release 11 — 12 months, dose 2
Symptoms: COVID 19 positive and secondary lung and sinus infections
Release 12 — day 42, dose 4
Symptoms: Sudden, large floater appeared in my right eye; was evaluated for a retina tear and no tear was found
Healthcare visit (other): Ophthalmologist
Release 12 — 3 months, dose 4
Symptoms: Extreme fatigue, shortness of breath, brain fog, headaches I have been diagnosed with long-COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Vitreous floaters | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Emotional disorder | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release